Zacks Investment Research upgraded shares of Sonova (OTCMKTS:SONVY) from a strong sell rating to a hold rating in a report issued on Friday morning.

According to Zacks, “Sonova Holding AG is a manufacturer of hearing care solutions. The company’s operating business brands consists of Phonak, Unitron, Advanced Bionics and AudioNova. Its product portfolio consists of hearing instruments and cochlear implants to wireless communication solutions. Sonova Holding AG is headquartered in Stäfa, Switzerland. “

Shares of Sonova (OTCMKTS:SONVY) opened at $31.51 on Friday. Sonova has a 52 week low of $24.89 and a 52 week high of $36.19. The company has a current ratio of 1.84, a quick ratio of 1.39 and a debt-to-equity ratio of 0.35.

COPYRIGHT VIOLATION NOTICE: “Sonova (SONVY) Upgraded to “Hold” at Zacks Investment Research” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at

Sonova Company Profile

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name.

Get a free copy of the Zacks research report on Sonova (SONVY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with's FREE daily email newsletter.